Capricor Therapeutics Inc (STU:4LN2) Stock News, Headlines & Updates
Capricor Therapeutics Inc Stock News from GuruFocus
- 1
- 2
- 3
- 4
Jul 22, 2025
Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CAPR
Business Wire • 4:00pm
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Capricor Therapeutics, Inc.(CAPR) Shareholders
Marketwired • 3:00pm
ROSEN, LEADING INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action -- CAPR
Marketwired • 2:00pm
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR
PRNewswire • 10:00am
Capricor Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Capricor Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 15, 2025 - CAPR
PRNewswire • 8:00am
CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit
PRNewswire • 7:00pm
Jul 21, 2025
Rosen Law Firm Urges Capricor Therapeutics, Inc. (NASDAQ: CAPR) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
Business Wire • 5:00pm
CAPR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
PRNewswire • 4:00pm
Gibbs Mura Announces a Securities Class Action Lawsuit Has Been Filed Against Capricor Therapeutics, Inc. (NASDAQ: CAPR); CAPR Investors Urged to Contact Award-Winning Firm, Gibbs Mura
Business Wire • 4:00pm
Capricor Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before September 15, 2025 to Discuss Your Rights -- CAPR
Marketwired • 4:00pm
Shareholders that lost money on Capricor Therapeutics, Inc.(CAPR) Urged to Join Class Action - Contact The Gross Law Firm to Learn More
PRNewswire • 8:00am
CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
PRNewswire • 7:00am
Jul 19, 2025
CAPRICOR ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Capricor Therapeutics, Inc. and Encourages Investors to Contact the Firm
Marketwired • 10:00am
Jul 18, 2025
CAPR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Marketwired • 3:01pm
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Capricor Therapeutics
Marketwired • 1:00pm
CAPRICOR THERAPEUTICS, INC. (NASDAQ: CAPR) INVESTOR ALERT: Investors With Large Losses in Capricor Therapeutics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
Marketwired • 12:00pm
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR
Marketwired • 11:00am
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Capricor Therapeutics, Inc. (CAPR)
Marketwired • 10:00am
CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Business Wire • 7:00pm
Jul 17, 2025
Shareholder Alert: Robbins LLP Informs Investors of the Capricor Therapeutics, Inc. Class Action
Marketwired • 6:00pm
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Capricor Therapeutics, Inc. (CAPR) Investors -- Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm
Marketwired • 5:00pm
BREAKING: Capricor Therapeutics Sued For Securities Fraud; Investors Should Contact Block & Leviton to Potentially Recover Losses
Marketwired • 4:00pm
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR
PRNewswire • 10:00am
Bragar Eagel & Squire, P.C. is Investigating Capricor Therapeutics, Inc. on Behalf of Capricor Stockholders and Encourages Investors to Contact the Firm
Marketwired • 7:00pm
Jul 14, 2025
Wolf Popper LLP Announces Investigation on Behalf of Capricor Therapeutics, Inc. Investors
Marketwired • 4:00pm
Capricor Therapeutics (CAPR) Price Target Lowered by Roth Capital | CAPR Stock News
GuruFocus News • 11:32am
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Capricor Therapeutics, Inc. - CAPR
Marketwired • 10:00am
Roth Capital Adjusts Capricor Therapeutics (CAPR) Price Target Following FDA Letter | CAPR Stock News
GuruFocus News • 8:45am
Capricor Therapeutics (CAPR) Faces Price Target Reduction Amid FDA Setback | CAPR Stock News
GuruFocus News • 6:31am
Jul 12, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR
PRNewswire • 10:00am
Jul 11, 2025
Capricor Therapeutics, Inc. (NASDAQ: CAPR) Securities Fraud Investigation; CAPR Investors Urged to Contact Award-Winning Firm, Gibbs Mura
Business Wire • 4:00pm
CAPR: HC Wainwright & Co. Adjusts Price Target for Capricor Therapeutics | CAPR Stock News
GuruFocus News • 1:33pm
INVESTOR ALERT: Investigation of Capricor Therapeutics, Inc. (CAPR) Announced by Holzer & Holzer, LLC
Marketwired • 1:00pm
Capricor Therapeutics (CAPR) Target Price Reduced by Cantor Fitzgerald | CAPR Stock News
GuruFocus News • 10:45am
Capricor Therapeutics (CAPR) Target Price Cut Amid Regulatory Setback | CAPR Stock News
GuruFocus News • 10:45am
Capricor Therapeutics (CAPR) Maintains Optimism Despite FDA Setback | CAPR Stock News
GuruFocus News • 10:16am
Capricor Therapeutics (CAPR) Maintains Buy Rating Amid FDA Feedback | CAPR Stock News
GuruFocus News • 10:16am
Capricor Therapeutics (CAPR) Shares Plunge After FDA Setback
GuruFocus News • 6:57am
Capricor (CAPR) Faces FDA Hurdle for Deramiocel Approval | CAPR Stock News
GuruFocus News • 6:16am
- 1
- 2
- 3
- 4
Show
Entries
Headlines
Total 0- 1
No recent news